JULIE BAUER: Open Payments
NPI 1255749719 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,893 in 115 payments from 22 companies in 2025. Trend: 2023 $2,220 · 2024 $1,519 · 2025 $2,893
Food & beverage: $2,893
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $340 |
| UCB, Inc. | 8 | $312 |
| LEO Pharma Inc. | 7 | $268 |
| ABBVIE INC. | 18 | $259 |
| Janssen Biotech, Inc. | 12 | $232 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $214 |
| Amgen Inc. | 5 | $196 |
| Incyte Corporation | 5 | $172 |
| Botanix SB Inc | 5 | $161 |
| GENZYME CORPORATION | 5 | $156 |
Products named: DUPIXENT, Bimzelx, TREMFYA, ANZUPGO, SKYRIZI, OTEZLA, OPZELURA, SOFDRA.
Industry payments across AZ — which companies pay providers there.
